Bladder-sparing, combined-modality appro
✍
Sisto Perdonà; Riccardo Autorino; Rocco Damiano; Marco De Sio; Brunello Morrica;
📂
Article
📅
2007
🏛
John Wiley and Sons
🌐
English
⚖ 133 KB
## Abstract ## BACKGROUND. The authors evaluated their long‐term experience with combined‐modality, conservative treatment in patients with muscle‐invasive bladder cancer. ## METHODS. In total, 121 patients with T2, T3, or T4 bladder cancer (mean age, 63 years; ratio of men to women, 3:1) underw